Report updated May 5, 2026
SimpliFASD
For medical prescribers and clinicians treating patients with FASD/ND-PAE.
Overview · Full Intel report in progress
SimpliFASD is an established health & fitness app that is completely free.
What is SimpliFASD?
Current Momentum
v958 · 11mo ago
MaintenanceLast updated 350d ago. 5 versions tracked.
Competition
Rivals identification in progress
7-Day Rank Pulse 🇺🇸
Health & FitnessNo ranking data
Rating Pulse 🇺🇸
Gathering signals...
What makes this app unique?
What Does It Look Like?
What Are The Key Features?
Categorizes patient symptoms into hyperarousal, emotional dysregulation, hyperactivity/neurocognitive, or cognitive inflexibility.
Provides algorithmic recommendations for first-line and second-line medications based on the identified primary symptom cluster.
Suggests specific adjunct therapies tailored to each of the four symptom clusters to improve patient daily functioning.
Supports data synchronization with the Apple Health app.
Includes a post-treatment survey feature to help evaluate the clinical impact of the decision tree recommendations.
How much does it cost?
Who Built It?
Avicenna Research
Facilitating academic and clinical research through a mobile-first data collection platform. Enabling researchers to gather real-world evidence via surveys and passive sensor tracking.
Portfolio
13
Apps
What other apps does Avicenna Research make?
Explore the full Avicenna Research report
Portfolio breakdown, audience, momentum, and every app published by Avicenna Research.
Analysis in progress, available soon
What do users think recently?
Analysis in progress, available soon
Analysis in progress, available soon
What is the competitive landscape for SimpliFASD?
How's The Health & Fitness Market?
Market outlook for this category
Available very soon
Strategic analysis coming soon
SWOT, key takeaways & outlook
The outtake for SimpliFASD
Key Takeaways
SimpliFASD provides a structured, evidence-based framework to standardize medication management and improve outcomes for patients with FASD/ND-PAE.
Where Is It Heading?
Trend analysis
Available very soon